Silo Pharma Inc. (SILO)
SILO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.22
-18.12% on the day
Market cap
$2.1M
Nano cap
Revenue · 2025
$72K
0.0% on 2024
Net income · 2025
-$4.2M
-5863.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | SILO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001514183 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $72K |
| Net income | -$4.2M |
| Operating income | -$4.3M |
| Net margin | -5863.5% |
| Operating margin | -5937.0% |
| Revenue growth | 0.0% |
| Cash | $4.7M |
| Total assets | $7.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 29.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2026-08-06 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-27 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-13 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-14 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2026-06-30 |
Source: SEC EDGAR submissions feed, 378 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PPBT | Purple Biotech Ltd. | $1.36 | -1.45% | $2.2M |
| GNPX | Genprex Inc. | $2.51 | -6.69% | $2.1M |
| OGEN | Oragenics Inc. | $0.4469 | -0.16% | $2.0M |
| SPRC | SciSparc Ltd. | $3.94 | -3.43% | $2.3M |
| ELAB | PMGC Holdings Inc. | $2.96 | -2.95% | $2.4M |
| MTNB | Matinas Biopharma Holdings Inc. | $2.50 | -8.76% | $2.4M |
| GOVX | GeoVax Labs Inc. | $0.2656 | -5.92% | $2.7M |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | $0.6939 | -5.08% | $1.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier